Loading clinical trials...
Loading clinical trials...
Evidence-based Modeling for Acquired Dyslexia Treatments
This study is a low-risk, early phase 1, multicenter trial to test the use of a computational (neural network) cognitive model of reading to simulate acquired dyslexia and its treatment. The aim is to determine whether there is an advantage to receiving the treatment the model predicts to be advantageous compared to the alternative treatment. All participants will receive two full rounds of treatment. A round of treatment will consist of either phonomotor treatment (PMT) or semantic feature analysis (SFA) for 60 hours, distributed over 5 days a week for 2 hours a day.
Age
18 - 85 years
Sex
ALL
Healthy Volunteers
No
Florida State University
Tallahassee, Florida, United States
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Kessler Foundation
West Orange, New Jersey, United States
Start Date
November 1, 2025
Primary Completion Date
September 1, 2026
Completion Date
September 1, 2026
Last Updated
October 7, 2025
12
ESTIMATED participants
Phono-Motor Therapy
BEHAVIORAL
Semantic Feature Analysis
BEHAVIORAL
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborators
NCT07371455
NCT05093673
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06258538